Grants per year
Personal profile
Research Interests
Pathogenesis & treatment of pituitary tumors, treatment of diabetic complications
Certifications and Licenses
| Internal Medicine | |
| Endocrinology, Diabetes & Metabolism |
Training Experience
| 1972 | Residency, Hospital of the University of Pennsylvania |
| 1975 | Fellowship, Univ. of CA-Los Angeles Med. Ctr. |
Education/Academic qualification
MD, University of Pennsylvania
… → 1969
Research interests
- Diabetes
- Endocrinology
- Medicine
- Metabolism
Fingerprint Dive into the research topics where Mark E Molitch is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 12 Similar Profiles
Prolactinoma
Medicine & Life Sciences
Pituitary Neoplasms
Medicine & Life Sciences
Prolactin
Medicine & Life Sciences
Type 1 Diabetes Mellitus
Medicine & Life Sciences
Therapeutics
Medicine & Life Sciences
Diabetic Nephropathies
Medicine & Life Sciences
Hyperprolactinemia
Medicine & Life Sciences
Insulin
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Grants 1999 2024
Prot#CRN00808-03: An Open Label Exploratory Study to Evaluate the Safety, Pharmacokinetics and Efficacy of CRN00808 in Patients with Acromegaly Treated with Somatostatin Analogue Based Treatment Regimens (ACROBAT EDGE)
Accelsiors CRO and Consultancy Services Ltd., Crinetics Pharmaceuticals, Inc.
8/6/19 → 8/6/22
Project: Research project
Prot#CRN00808-02: A Double-blind, Placebo-controlled, Randomized Withdrawal Study to Evaluate the Safety, Pharmacokinetics and Efficacy of CRN00808 in Patients with Acromegaly that are Responders to Octreotide Lar or Landreotide (ACROBAT EVOLVE)
Accelsiors CRO and Consultancy Services Ltd., Crinetics Pharmaceuticals, Inc.
8/6/19 → 8/6/22
Project: Research project
Epidemiology of Diabetes Interventions and Complications (EDIC)
Molitch, M. E., El Muayed, M. & Wallia, A.
Case Western Reserve University, National Institute of Diabetes, Digestive and Kidney Diseases
7/1/19 → 6/30/20
Project: Research project
National Institute of Diabetes and Digestive and Kidney Diseases (U.S.)
Diabetes Complications
Epidemiology
DNA
Prot#CLCI699C2X01B: An Open-label, Multi-Center, Roll-Over Study to Assess Long Term Safety in Patients with Endogenous Cushing’s Syndrome Who Have Completed a Prior Novartis-Sponsored Osilodrostat (LCI699) Study and are Judged by the Investigator to Bene
Novartis Pharmaceuticals Corporation
5/22/19 → 12/31/24
Project: Research project
Preventing Early Renal Loss Follow-up Study (PERLage)
Joslin Diabetes Center, Inc., JDRF International
5/16/19 → 10/31/20
Project: Research project
Research Output 1969 2019
8
Citations
(Scopus)
Cardiorenal Syndrome: Classification, Pathophysiology, Diagnosis, and Treatment Strategies: A Scientific Statement From the American Heart Association
American Heart Association Council on the Kidney in Cardiovascular Disease and Council on Clinical Cardiology, Apr 16 2019, In : Circulation. 139, 16, p. e840-e878Research output: Contribution to journal › Article
Open Access
Cardio-Renal Syndrome
Kidney
Therapeutics
Palliative Care
Diabetes Mellitus
1
Citation
(Scopus)
Early Glomerular Hyperfiltration and Long-Term Kidney Outcomes in Type 1 Diabetes: The DCCT/EDIC Experience
Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Research Group, Jun 7 2019, In : Clinical journal of the American Society of Nephrology : CJASN. 14, 6, p. 854-861 8 p.Research output: Contribution to journal › Article
Diabetes Complications
Type 1 Diabetes Mellitus
Diabetic Nephropathies
Iothalamic Acid
Proportional Hazards Models
Pituitary Tumors in Pregnancy
Huang, W. & Molitch, M. E., Sep 1 2019, In : Endocrinology and Metabolism Clinics of North America. 48, 3, p. 569-581 13 p.Research output: Contribution to journal › Review article
Pituitary Neoplasms
Pregnancy
Pituitary Hormones
Prolactinoma
Pituitary ACTH Hypersecretion
Pregnancy and Endocrine Disorders
Molitch, M. E., Sep 1 2019, In : Endocrinology and Metabolism Clinics of North America. 48, 3, p. xv-xviResearch output: Contribution to journal › Editorial
Pregnancy
3
Citations
(Scopus)
Preventing Early Renal Loss in Diabetes (PERL) Study: A Randomized Double-Blinded Trial of Allopurinol-Rationale, Design, and Baseline Data
PERL Study Group, Aug 1 2019, In : Diabetes care. 42, 8, p. 1454-1463 10 p.Research output: Contribution to journal › Article
Allopurinol
Diabetic Nephropathies
Uric Acid
Glomerular Filtration Rate
Albuminuria